FDA Public Meeting on the Recommendations for Biosimilar User Fee Act (BsUFA) Reauthorization

 Link DisclaiThe Food and Drug Administration (FDA or Agency) is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2023 through 2027. The virtual public meeting will be held on November 2, 2021, from 9 a.m. to 12 p.m. (ET). The meeting agenda, public docket information, additional materials, and any other updates will also be posted to this website as they become available.

You can register for the meeting hereExternal Link Disclaimer to let FDA know that you plan to attend. Though registration is voluntary and not required to attend, registrants will receive email updates and notices when new information becomes available.

Date: November 2, 2021

Time: 9:00 AM - 12:00 PM ET

• Federal Register Notice

Webinar Information:
https://fda.zoomgov.com/j/1610478285?pwd=MG1lN2hrYzBVTGhsd1F2eVhwZG1DQT09External Link Disclaimer

Webinar Meeting ID:
161 047 8285

Webinar Password (Case-Sensitive):
S9d&fx

Attend
Register for this EventExternal Link Disclaimer

[DEADLINE EXTENDED!] If you wish to make a verbal comment during the open public comment portion of the meeting, please submit the request formExternal Link Disclaimer (also available on the Eventbrite pageExternal Link Disclaimer) by 11:59pm (ET) on October 26th.